期刊文献+

支气管灌洗液Survivin基因检测在肺癌诊断中的价值 被引量:3

Diagnositic value of expression of survivin in bronchial lavage fluid of lung cancer
下载PDF
导出
摘要 目的探讨支气管灌洗液(BLF)标本Survivin m R N A检测在肺癌尤其是周围型肺癌诊断中的可行性及应用价值。方法应用逆转录-聚合酶链反应(R T-PC R)方法,分别检测124例肺癌、103例支气管肺部良性疾病患者BLF标本Survivin m R N A表达情况,并与BLF标本细胞病理学等结果相比较。结果 BLF标本Survivin m R N A表达阳性率肺癌患者45.2%(56/124),显著高于支气管肺部良性疾病患者18.4%(19/103),差异有统计学意义(χ2=18.150,P=0.000)。BLF标本Survivin m R N A相对表达量与肺癌病理类型、分化程度均相关(均P<0.05);而与肺癌患者的性别、年龄、抽烟史、肿瘤的部位、大小、淋巴结转移、远处转移、临床分期及中心型肺癌患者BLF方式之间均无明显相关(均P>0.05)。BLF标本检测Survivin m R N A诊断肺癌的敏感性、特异性分别为45.2%(56/124)和81.6%(84/103),诊断周围型肺癌的敏感性、特异性分别为35.9%(14/39)和85.4%(88/103)。BLF标本检测Survivin m R N A表达联合细胞病理学检查阳性率为57.5%(65/113),显著高于单独检测Survivin m R N A阳性率43.4%(49/113)或细胞病理学阳性率23.9%(27/113),差异均有统计学意义(χ2=4.531,26.472,P=0.033,0.000)。结论 BLF标本Survivin m R N A可能成为肺癌诊断有价值的肿瘤标志物之一,为肺癌尤其是周围型肺癌早期诊断提供帮助,BLF标本获取方式不影响Survivin m R N A表达检测结果。 【Objective】To explore the feasibility and value of detecting survivin messenger RNA in BLF specimens as tumor makers for earlier diagnosis of lung cancer,especially peripheral lung cancer.【Methods】Specimens of BLF were form 124 cases suffering from lung cancer and 103 cases suffering from pulmonary benign diseases respectively.The expression of mRNA of survivin in specimens was detected with the method of reverse polymerase chain reaction(RT-PCR),and compared with the cytopathological examinations.【Results】The positive rate of survivin mRNA in BLF of lung cancer 45.2%(56/124) was sharply higher than that 18.4%(19/103) of pulmonary benign diseases(χ2=18.150,P =0.000).There were correlation between survivin mRNA expression and histopathological subtype,differentiation(all P 0.05),while there were no relationships between survivin mRNA expression and sex,age and smoking of patients,and site,size,lymph node metastases,distant metastasis and clinical stages of lung cancer,and different bronchial lavage sequences(all P 0.05).By detecting survivin mRNA,the sensibility and specificity of the diagnosis for lung cancer were respectively: 45.2%,81.6%,for peripheral lung cancer were respectively: 35.9%,85.4%.There were significant difference between the positive rate(57.5%) of survivin mRNA combined with cytopathological examination and that(43.4%) of survivin mRNA,that(23.9%) of cytopathological examination in BLF specimens(χ2=4.531,26.472;P =0.033,0.000).【Conclusions】Survivin mRNA in BLF might be used as the specific molecular marker for diagnosis of lung cancer,especially of peripheral lung cancer.The outcome of expression of survivin mRNA doesn't be affected by the different bronchial lavage sequences.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第8期45-50,共6页 China Journal of Modern Medicine
关键词 肺癌 支气管灌洗液 SurvivinmRNA lung cancer bronchoal lavage fluid survivin mRNA
  • 相关文献

参考文献4

二级参考文献79

共引文献53

同被引文献58

  • 1Jemal A, Bray F, Center M M, et al. Global cancer statistics[ J]. CA Cancer J Clin,2011,61(2) :69-90.
  • 2Jemal A,Siegel R,Ward E,et al. Cancer statistics[J]. CA Cancer J Clin,2007,57( 1 ) :43-66.
  • 3Henschke C I, Yankelevitz D F, Libby D M, et al. Survival of pa- tients with stage I lung cancer detected on CT screening[ J]. N Engl J Med, 2006, 355 (17) : 1763-1771.
  • 4Groome PA, Bolejack V, Cruwley J J, et al. The IASLC Lung Cancer Staging Project : validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tulnours [ J ]. J Thorac Oncol, 2007,2 ( 8 ) :694-705.
  • 5Bremnes R M, Sirera R, Camps C. Circulating tumor derived DNA and RNA markers in blood:a tool for early detection diagnostics, and follow up [ J ]. Lung Cancer,2005,49 (1) :1-12.
  • 6Kneip C, Schmidt B, Seegebarth A, et al. SHOX2 DNA methyla- tion is a biomarker for the diagnosis of lung cancer in plasma[ J~. J Thorac Oncol, 2011,6 ( 10 ) : 1632-1638.
  • 7Begum S, Brait M, Dasgupta S, et al. An epigenetic marker panel for detection of lung cancer using cell-free serum [ J ]. Clin Cancer Res, 2011,17 ( 13 ) :4494 - 4503.
  • 8Hwang S H,kim J E,Kim H H, et al. Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from pri- mary lung cancer patients [ J ]. Clin Chem Lab Med, 2011 , 49 (4) : 699-704.
  • 9Belinsky S A, Liechty K C, Gentry F D, et al. Promoter hyperm- ethylation of multiple genes in sputum precedes lung cancer inci- dence in a high-risk cohort [ J ]. Cancer Res, 2006, 66 (6) : 3338-3344.
  • 10Van der Drift M A, Prinsen C F, Knuiman G J, et al. Diagnosis peripheral lung cancer: the additional value of RASSF1A methyla- tion and KRAS mutation analyses in washings in non-diagnostic bronchoscopy[ J]. Chest,2012,141 ( 1 ) :169-175.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部